Developing drugs targeting CX3CL1 to treat heart diseases via immune/inflammatory mediation

• Zou Lin,
• Ma Junhua,
• Hu Guiying,
• Zhu Hongling,
• Zhang Lijuan,
• Li Xiangqi

Affiliations

Zou Lin

["Department of Endocrinology and Metabolism, Gongli Hospital, Naval Medical University, Shanghai 200135, China"]

Ma Junhua

["Department of Endocrinology and Metabolism, Gongli Hospital, Naval Medical University, Shanghai 200135, China"]

Hu Guiying

["Outpatient Department, Zhongxian People’s Hospital, Chongqing 404300, China"]

Zhu Hongling

["Department of Endocrinology and Metabolism, Gongli Hospital, Naval Medical University, Shanghai 200135, China"]

Zhang Lijuan

["Department of Endocrinology, Shanghai Songjiang District Center Hospital, Shanghai 201600, China"]

Li Xiangqi

["Department of Endocrinology and Metabolism, Gongli Hospital, Naval Medical University, Shanghai 200135, China"]